Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vilaprisan vs non-hormonal standard therapy in uterine fibroids
CTR20170439Phase 3Terminated
- Sponsor
- Bayer
- Start
- Aug 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vilaprisan in Fibromyoma (LM), sponsored by Bayer. Started Aug 2017; status: terminated.
02
Drugs
vilaprisan
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on CTR20170439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170439.